Edition:
United Kingdom

Radius Health Inc (RDUS.OQ)

RDUS.OQ on NASDAQ Stock Exchange Global Market

18.96USD
19 Oct 2018
Change (% chg)

$-0.52 (-2.67%)
Prev Close
$19.48
Open
$19.49
Day's High
$19.88
Day's Low
$18.83
Volume
222,511
Avg. Vol
261,745
52-wk High
$41.14
52-wk Low
$16.71

Chart for

About

Radius Health, Inc. is a biopharmaceutical company. The Company is focused on the developing therapeutics in the areas of osteoporosis, oncology and endocrine diseases. The Company's lead investigational product candidate, TYMLOS (abaloparatide-SC) injection is developed for the treatment of postmenopausal women with osteoporosi... (more)

Overall

Beta: 1.31
Market Cap(Mil.): $1,686.22
Shares Outstanding(Mil.): 43.50
Dividend: --
Yield (%): --

Financials

  RDUS.OQ Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -5.19 -- --
ROI: -75.07 0.21 14.27
ROE: -75.11 1.17 15.99

BRIEF-Radius Health Reports Q1 Loss Per Share Of $1.37

* RADIUS HEALTH REPORTS FIRST QUARTER 2018 FINANCIAL AND OPERATING RESULTS AND PROVIDES BUSINESS UPDATE

10 May 2018

Earnings vs. Estimates